140 related articles for article (PubMed ID: 21826737)
1. The prevalence and clinical-demographic correlates of diabetes mellitus in chronic schizophrenic patients receiving clozapine.
Zhang R; Hao W; Pan M; Wang C; Zhang X; Chen DC; Xiu MH; Yang FD; Kosten TR; Zhang XY
Hum Psychopharmacol; 2011 Aug; 26(6):392-6. PubMed ID: 21826737
[TBL] [Abstract][Full Text] [Related]
2. Diabetes mellitus among outpatients receiving clozapine: prevalence and clinical-demographic correlates.
Lamberti JS; Costea GO; Olson D; Crilly JF; Maharaj K; Tu X; Groman A; Dietz MB; Bushey MP; Olivares T; Wiener K
J Clin Psychiatry; 2005 Jul; 66(7):900-6. PubMed ID: 16013906
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications.
Hägg S; Joelsson L; Mjörndal T; Spigset O; Oja G; Dahlqvist R
J Clin Psychiatry; 1998 Jun; 59(6):294-9. PubMed ID: 9671341
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
[TBL] [Abstract][Full Text] [Related]
5. Undiagnosed hyperglycemia in clozapine-treated patients with schizophrenia.
Sernyak MJ; Gulanski B; Leslie DL; Rosenheck R
J Clin Psychiatry; 2003 May; 64(5):605-8. PubMed ID: 12755666
[TBL] [Abstract][Full Text] [Related]
6. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study.
Henderson DC; Cagliero E; Gray C; Nasrallah RA; Hayden DL; Schoenfeld DA; Goff DC
Am J Psychiatry; 2000 Jun; 157(6):975-81. PubMed ID: 10831479
[TBL] [Abstract][Full Text] [Related]
7. [Therapy with antipsychotic drugs as a risk factor for diabetes in schizophrenia: a case-control study].
Rubio G; Gómez-de-la-Cámara A; Ledesma F; Burón JA; Rodríguez-Morales A; Martínez-Junquera G;
Med Clin (Barc); 2006 Apr; 126(12):441-4. PubMed ID: 16620729
[TBL] [Abstract][Full Text] [Related]
8. A twenty-four-week, open-label study on ziprasidone's efficacy and influence on glucolipid metabolism in patients with schizophrenia and metabolic disorder.
Li CH; Shi L; Zhan GL; Rao SZ; Zhang H
Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2136-40. PubMed ID: 23893178
[TBL] [Abstract][Full Text] [Related]
9. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
[TBL] [Abstract][Full Text] [Related]
10. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF
J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus associated with clozapine therapy.
Wehring H; Alexander B; Perry PJ
Pharmacotherapy; 2000 Jul; 20(7):844-7. PubMed ID: 10907975
[TBL] [Abstract][Full Text] [Related]
12. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
Stanković Z; Britvić D; Vuković O; Ille T
Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
[TBL] [Abstract][Full Text] [Related]
13. A cross-sectional evaluation of adiponectin plasma levels in patients with schizophrenia and schizoaffective disorder.
Hanssens L; van Winkel R; Wampers M; Van Eyck D; Scheen A; Reginster JY; Collette J; Peuskens J; De Hert M
Schizophr Res; 2008 Dec; 106(2-3):308-14. PubMed ID: 18930377
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of tardive dyskinesia in chronic male inpatients with schizophrenia on long-term clozapine versus typical antipsychotics.
Ye M; Tang W; Liu L; Zhang F; Liu J; Chen Y; Chen DC; Tan YL; Yang FD; Hong Xiu M; Hui L; Lv MH; Soares JC; Zhang XY
Int Clin Psychopharmacol; 2014 Nov; 29(6):318-21. PubMed ID: 24803102
[TBL] [Abstract][Full Text] [Related]
15. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in the prevalence of diabetes mellitus in chronic hospitalized patients with schizophrenia on long-term antipsychotics.
Chen DC; Zhou MA; Zhou DH; Xiu MH; Wu GY; Kosten TR; Zhang XY
Psychiatry Res; 2011 Apr; 186(2-3):451-3. PubMed ID: 20797801
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of diabetes mellitus in patients receiving depot neuroleptics or clozapine.
Miller MJ; Molla PM
Arch Psychiatr Nurs; 2005 Feb; 19(1):30-4. PubMed ID: 15765369
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
Brunero S; Lamont S; Fairbrother G
Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
[TBL] [Abstract][Full Text] [Related]
20. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
